VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bill Fischofer who wrote (5677)	2/26/1998 5:53:00 PM
From: Richard Singer	Read Replies (1) of 23519

Bill, Bill, Bill Macrochem is certainly not an earnings play. No one would buy it as such. Macrochem is a product development play - a SPECULATION on the success or failure of products in their pipeline-most promising, at the moment, TOPIGLAN which has shown similar efficacy to MUSE. I am not a physician. On the other hand,I'm not so sure I want to abandon my position, solely on the nay-sayso of Mr.Voss, even though I have great respect for him and his accomplishments. I just think maybe, sometimes the forest gets lost in all the damn trees! What if Mr.Voss is incorrect in his opinion that TOPIGLAN will never be approved? As a prostate cancer survivor with ED, I will gladly give the snake gel a go. The most disappointing thing MCHM has done recently is file the TM TOPIGLAN.......we on the Macrochem thread prefer 'SWELLGEL' Good luck, Richard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next